View Article

  • Pathophysiology of Diabetes Mellitus with Disease Economics

  • 1,2Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad, Dr. Babasaheb Ambedkar Technological University, Lonere, Raigad MS India- 415509.

    3Associate Professor, Shri Ganpati Institute of Pharmaceutical Sciences and Research, Tembhurni, Dr. Babasaheb Ambedkar Technological University, Lonere, Raigad MS India- 413211.

Abstract

Diabetes mellitus is a serial metabolic disorder characterized by hyperglycemia, which arises due to irregular in insulin secretion, insulin action, or both. This condition affects millions worldwide, making it one of the most pressing health challenges of the 21st century. The number of people living with diabetes rose from 200 million in 1990 to 830 million in 2022. Prevalence has been rising more rapidly in low- and middle-income countries than in high-income countries. The global prevalence of diabetes has been rising rapidly, driven by increasing rates of obesity, sedentary lifestyles, and aging populations. Present review includes basic introduction of diabetes mellitus disease, disease pathophysiology, etiology, sign and symptoms, treatment and prevention control, complications and current disease statistics in India and global scinerio.

Keywords

Diabetes mellitus, Hyperglycemia, Insulin, Obesity, Polyuria, Polydipsia, Retinopathy, Gestational Diabetes, wound healing etc.

Introduction

The word "diabetes" comes from the Greek word diabainein, which means "to pass through" or "siphon." This reflects the condition's early symptom of excessive urination, as if fluids were "passing through" the body. The term "mellitus" is derived from the Latin word for "honey" or "sweet," referring to the presence of sugar in the urine of people with the condition. Together, Diabetes Mellitus essentially means "siphoning off sweet urine," a characteristic identified in historical medical observations. Diabetes is a long-standing disorder. Diabetes is chronic medical condition characterized by elevated blood glucose levels, which can result from defects in insulin production, insulin action, or both. Effective management and diagnosis of diabetes are crucial to prevent complications. In diabetes patient body risk factors mainly include are obesity, metabolic and cardiovascular disorder. Diabetes belongs to one of the largest global health crises of this century. India has the second-largest number of diabetics worldwide. According to an estimate, over 74 million Indians were diagnosed with diabetes in 2021, and this is expected to rise to over 124 million by 2045 (Statista, 2023). The International Diabetes Federation (IDF) research India predicts 40.9 million patients are observed in 2024. This case is increasing to 69.9 million around in 2025. The number of people with diabetes worldwide has more than doubled during the past 20 years. One of the most worrying features of this rapid increase is the emergence of type 2 diabetes in children, adolescents, and young adults.[1] Increased risk for diabetes is primarily associated with age, ethnicity, family history of diabetes, smoking, obesity, and physical inactivity. Diabetes-related complications including cardiovascular disease, kidney disease, neuropathy, blindness, and lower-extremity amputation are a significant cause of increased morbidity and mortality among people with diabetes, and result in a heavy economic burden on the health care system.[2]

Classification of Diabetes

Blood glucose rises because it cannot be metabolized in the cells, due to lack of insulin production by the pancreas or the inability of the cells to effectively use the insulin that is being produced.[3] The first time WHO (World Health Organization) advertised, in classification of diabetes in 1980, but change in 1985. Diabetes is classified into 3 types as,

  1. Type - I diabetes
  2. Type - II diabetes
  3. Gestational diabetes

Type - I diabetes

In type I diabetes, patient’s pancreas does not make insulin or makes very little insulin. Type I diabetes can affect people at any age, but commonly develops in children and young adults. People living with type I diabetes need daily insulin injections to control their blood glucose levels. This type I diabetes mellitus cases are 5-10% in all cases of diabetes patient. It is indicated by autoimmune breaking up of the pancreatic beta cells. Type I diabetes, control needed a quiet of insulin injection in daily life. Insulin pump remedial treatment is included of control diabetes as well as glucose superintend. This disorder is observed in children, and grown person. Type I diabetes cannot currently be prevented and there is no cure for the condition.

Major symptoms of type I diabetes mainly include abnormal thirst and dry mouth, sudden weight loss, frequent urination, lack of energy, tiredness, constant hunger, blurred vision and bedwetting etc.

Type - II diabetes

Diabetes mellitus is the oldest disorder, it is first described in Ethiopian manuscript in 3000-year-old. And 1936 division of type 1 diabetes and type 2 diabetes are described. Type II diabetes is a chronic metabolic disorder characterized by high blood glucose levels due to the body's ineffective use of insulin, a hormone that regulates blood sugar. Normally, insulin binds to its receptor on the cell membrane, triggering a cascade that allows glucose transporters (GLUT4) to move to the cell surface and take up glucose by different mechanism like Insulin Resistance, Compensatory Hyperinsulinemia, Beta-Cell Dysfunction and also liver contributes to hyperglycemia in type II Diabetes by producing excessive glucose through gluconeogenesis. In Adipose Tissue Dysfunctioning insulin resistance in fat cells results in increased lipolysis (breakdown of fat), releasing free fatty acids into the bloodstream. Elevated free fatty acids further impair insulin action and exacerbate insulin resistance in other tissues like muscle and liver. Incretin hormones (e.g., GLP-1 and GIP), which are released from the gut after eating, enhance insulin secretion. In type II Diabetes, there is reduced incretin effect, contributing to inadequate insulin secretion.[4]

Major symptoms of type II diabetes include Increased Thirst and Frequent Urination, Increased Hunger (Polyphagia), Unexplained Weight Loss, Fatigue, Blurred Vision, Slow-Healing Sores or Frequent Infections, Darkened Skin in Certain Areas (Acanthosis Nigricans), Tingling or Numbness in Hands or Feet (Neuropathy).

Gestational Diabetes

Gestational diabetes mellitus is a form of glucose intolerance diagnosed during pregnancy, typically in the second or third trimester, that is not overt diabetes. It occurs due to the physiological adaptations of pregnancy, combined with a predisposition to insulin resistance and beta-cell dysfunction. It poses risks for both the mother and the newborn and increases the likelihood of developing Type 2 Diabetes later in life.[5]

During pregnancy, placental hormones such as human placental lactogen (hPL), progesterone, cortisol, and prolactin promote insulin resistance to ensure adequate glucose supply to the fetus. Polymorphisms in genes related to glucose metabolism, insulin signaling, and beta-cell function (e.g., TCF7L2, KCNQ1) increase susceptibility. Epigenetic changes during pregnancy (e.g., DNA methylation) can influence metabolic pathways and contribute to GDM. A study showed that maternal insulin sensitivity decreases by 50-60% during the third trimester due to the combined effects of placental hormones. GDM occurs when beta-cells cannot overcome this resistance identified that women with GDM have a reduced first-phase insulin response to glucose, indicating impaired beta-cell compensation. A meta-analysis by Lappas (2010) reported elevated levels of pro-inflammatory cytokines like TNF-? and IL-6 in women with GDM, correlating with increased insulin resistance. Catalano demonstrated that higher pre-pregnancy BMI is associated with increased circulating FFAs, which impair insulin signaling. Kwakernaak (2016) highlighted polymorphisms in TCF7L2 as a significant risk factor for GDM due to its role in beta-cell function and glucose regulation. Epigenetic modifications (e.g., altered DNA methylation in offspring of GDM mothers) have been implicated in intergenerational transmission of metabolic disorders.[6]

Sign and symptoms of diabetes

The outstanding symptoms of diabetes are the polyuria, polydipsia, polyphagia. It is observed in type 1 diabetes and quick evolution are the hyperglycemia, in type 2 diabetes. With loss, fatigue, and body pain are common sign of diabetes. The common sign and symptoms of diabetes.

Frequent Urination (Polyuria): Hyperglycemia exceeds the renal threshold for glucose reabsorption (~180 mg/dL), causing glucosuria (glucose in urine). Glucose draws water osmotically into the urine, leading to osmotic diuresis and increased urine output.

Increased Thirst (Polydipsia): Excessive thirst is a compensatory mechanism as the body attempts to replace lost fluid form frequent Urination. Osmotic diuresis from glucose excretion leads to dehydration and loss of electrolytes. Dehydration triggers the hypothalamus to stimulate thirst via osmoreceptors, resulting in polydipsia.

Increased Hunger (Polyphagia): In type I diabetes, lack of insulin prevents glucose uptake by cells, creating a state of perceived cellular starvation. In type II diabetes, insulin resistance leads to impaired glucose utilization, also triggering hunger signals from the hypothalamus. It is increased the hunger result from the body in capability to exploit the glucose properly, primary feeling of non-stop hunger.

Fatigue: Decreased insulin effectiveness (resistance or deficiency) reduces glucose uptake by cells, leading to insufficient ATP production. Muscle breakdown (proteolysis) and fat breakdown (lipolysis) for alternative energy sources can further contribute to fatigue.  

Blurred Vision: High blood glucose levels cause fluid shifts into the lens, altering its shape and refractive index. Chronic hyperglycemia can also damage retinal blood vessels (diabetic retinopathy), leading to vision changes over time.

Slow-Healing Wounds or Frequent Infections:

Hyperglycemia impairs immune function by reducing phagocytosis and neutrophil activity. Poor circulation from vascular damage (microangiopathy) reduces oxygen and nutrient delivery to tissues, delaying wound healing. High glucose levels create a favorable environment for bacterial and fungal growth.

Unexplained Weight Loss:

In type I diabetes, lack of insulin leads to rapid breakdown of fat (lipolysis) and muscle (proteolysis) for energy. In type II diabetes, severe insulin resistance and catabolism contribute to weight loss. Glucosuria also causes calorie loss.

Tingling or Numbness in Hands and Feet (Peripheral Neuropathy):

Chronic hyperglycemia causes damage to peripheral nerves by oxidative stress, inflammation, and sorbitol accumulation via the polyol pathway. Poor circulation exacerbates nerve damage.

Darkened Skin Patches (Acanthosis Nigricans):

Chronic hyperinsulinemia in type 2 diabetes stimulates keratinocyte and fibroblast proliferation via insulin-like growth factor receptors, causing thickened, pigmented skin.

Frequent Infections:

High blood sugar levels weaken the immune system by impairing macrophage and neutrophil function. Hyperglycemia also provides an energy source for pathogens, increasing susceptibility to infections.

Sweet or Fruity-Smelling Breath (Ketoacidosis in Type 1 Diabetes):

In diabetic ketoacidosis, lack of insulin leads to excessive fat breakdown and ketone body production. One ketone, acetone, is exhaled, giving a fruity smell.

Complication of diabetes

Diabetic Ketoacidosis (DKA): Insulin deficiency leads to unregulated lipolysis, resulting in excessive free fatty acids (FFAs). FFAs are converted to ketone bodies (?-hydroxybutyrate, acetoacetate) in the liver, leading to metabolic acidosis. Nausea, vomiting, abdominal pain, fruity breath (from acetone), rapid breathing (Kussmaul respirations), altered mental state are major symptoms. Electrolyte imbalances, cerebral edema, or death if untreated.

Hyperosmolar Hyperglycemic State (HHS):

Severe hyperglycemia (>600 mg/dL) without significant ketoacidosis. Osmotic diuresis causes dehydration and hyperosmolality (>320 mOsm/L), impairing brain function. Symptoms seen in HHS are extreme thirst, confusion, seizures, coma. Severe dehydration, shock, or death if untreated.

Hypoglycemia: Overdose of insulin or oral hypoglycemic agents, missed meals, or excessive exercise causes Hypoglycemia. Sweating, tremors, palpitations, confusion, seizures, or loss of consciousness.

Retinopathy: Hyperglycemia damages retinal capillaries through oxidative stress, advanced glycation end products (AGEs), and VEGF (vascular endothelial growth factor) activation leads to capillary leakage, ischemia, and neovascularization.

Nephropathy: Chronic hyperglycemia causes glomerular hyperfiltration, basement membrane thickening, and podocyte loss may lead to proteinuria, hypertension, and reduced glomerular filtration rate (GFR). In this main symptom include microalbuminuria (early sign), progressing to proteinuria and eventually end-stage kidney disease (ESKD).

Neuropathy: Diabetes mellitus is the most common causes of neuropathy worldwide. Hyperglycemia damages peripheral nerves through sorbitol accumulation (via the polyol pathway), oxidative stress, and ischemia.

Peripheral Neuropathy: Tingling, burning, or numbness in hands/feet.

Autonomic Neuropathy: Affects internal organs, causing gastroparesis, erectile dysfunction, or orthostatic hypotension. Focal Neuropathy: Sudden weakness or pain in specific nerves (e.g., cranial or femoral). Uncontrolled diabetes leads to complications in many organs. Damage to small and large blood vessels and nerves leads to loss of vision and kidney function, heart attacks, strokes, and lower limb amputations. Diabetes causes disability and shortens lives.[3] 

Diagnosis of Diabetes:

Diabetes diagnosis involves identifying abnormally high blood glucose levels to ensure timely treatment and prevent complications. Early detection of diabetes is crucial for effective management, as untreated diabetes can lead to significant acute and chronic health issues.  Early diagnosis allows for timely intervention, reducing the risk of microvascular complications (like retinopathy, nephropathy, neuropathy) and macrovascular complications (like cardiovascular disease, stroke). Early management of blood sugar levels minimizes symptoms like fatigue, polyuria, and infections, improving daily functioning. Detecting diabetes early avoids costly hospitalizations and treatments for complications. Also identifying prediabetes enables lifestyle modifications to prevent progression to full-blown diabetes.[7]


Test

Preparation

Sample taken

Purpose

Fasting plasma glucose (FPG)

8-hour fasting

Blood sample

Screens for prediabetes/diabetes.

Oral Glucose Tolerance Test (OGTT)

Fasting, glucose drink

Blood samples pre and post-glucose

Assesses glucose metabolism and insulin response.

Hemoglobin A1C Test (HbA1C)

None

Blood sample

Diagnoses diabetes; monitors control over time.

Random Plasma Glucose Test (RPG)

None

Blood sample

Quick screening when symptoms are present.

C-Peptide Test

None

Blood sample

Differentiates type I and type II diabetes.

Autoantibody Testing

None

Blood sample

Diagnoses autoimmune forms of diabetes.


Some Test of diabetes-

1. Fasting plasma glucose   (FDG) Test

2. Oral glucose tolerance     (OGTT) test.

3. Hemoglobin A1C (HbA1C) test

4. Random plasma glucose test.

1. Fasting plasma glucose test (FPG):-

The Fasting Plasma Glucose (FPG) test is a simple and widely used diagnostic test for diabetes and prediabetes. The patient is instructed to fast for at least 8 hours (no food or drink except water). Avoid heavy physical activity, alcohol, and smoking during the fasting period, as these can affect glucose levels. A healthcare professional collects a venous blood sample from the patient. The blood sample is placed in a tube containing an anticoagulant (e.g., sodium fluoride or EDTA) to prevent clotting and glycolysis (breakdown of glucose in the blood sample). The collected blood sample is sent to a laboratory for glucose measurement by Automated Biochemistry Analyzers using enzymatic methods (e.g., glucose oxidase or hexokinase assay) to measure glucose concentrations or Point-of-Care (POC) Devices like glucometers.


Table: FPG, HbA1C 7 OGTT test levels

 

 

 

Fasting Plasma Glucose (FPG)

Hemoglobin A1C Levels

Oral Glucose Tolerance Test (OGTT)

(2-Hour Plasma Glucose Level)

Normal

Less than 100 mg/dL

Below 5.7%

Less than 140 mg/dL

Prediabetes

100 to 125 mg/dL

5.7% to 6.4%

140 to 199 mg/dL

Diabetes Mellitus

126 mg/dL or higher

6.5% or over

200 mg/dL or higher


2. Oral glucose tolerance test (OGTT):-

The Oral Glucose Tolerance Test (OGTT) is a diagnostic test that evaluates how efficiently the body processes glucose. It is primarily used to diagnose diabetes mellitus, gestational diabetes, and prediabetes. The patient must fast for 8–12 hours before the test (no food or drink except water). Avoid smoking, caffeine, and strenuous physical activity during the fasting period. A healthcare professional collects a fasting blood sample to measure baseline blood glucose levels. The patient drinks a glucose solution (typically 75 grams of glucose dissolved in water for adults). For gestational diabetes screening, a 50-gram or 100-gram glucose solution may be used, depending on the protocol. Blood samples are collected at specific intervals (commonly 30 minutes, 1 hour, and 2 hours after ingestion of the glucose solution). These samples measure how quickly and effectively glucose is cleared from the bloodstream. Patients may resume their regular diet and activities after the test.

3. Haemoglobin A1C test:-

The Hemoglobin A1C (HbA1c) test is a critical diagnostic and monitoring tool for diabetes. It reflects the average blood glucose levels over the past 2–3 months, providing a comprehensive picture of glucose control. An HbA1 level of 6.5% or higher is used to diagnosis diabetes. This test is helpful of observing ongoing management of diabetes. This test helps to assess the severity of hyperglycemia. Higher HbA1c levels correlate with an increased risk of diabetes-related complications like cardiovascular disease, neuropathy, nephropathy, and retinopathy.

Hemoglobin is a protein in red blood cells responsible for carrying oxygen. Glucose binds to hemoglobin in the bloodstream, forming glycated hemoglobin (HbA1c). The HbA1c test measures the percentage of total hemoglobin that is glycated, reflecting average glucose exposure over the lifespan of a red blood cell (~120 days). No fasting or special preparation is required, making it more convenient than fasting glucose or OGTT.

4. Random plasma glucose test (RPG) :-

The Random Plasma Glucose (RPG) Test is a diagnostic tool that measures blood glucose levels at any time of the day, regardless of the last meal. It is particularly useful in identifying hyperglycemia in symptomatic individuals. This test calculated blood glucose level anytime of the day without fasting. Result of 200 mg DL couple with symptoms of diabetes can identified diabetes. Blood glucose levels are regulated by insulin (hormone lowering glucose) and glucagon (hormone increasing glucose). In diabetes, either insufficient insulin production or insulin resistance causes elevated glucose levels, which can be detected by an RPG test. The RPG test plays a critical role in identifying diabetes and hyperglycemia in symptomatic individuals, facilitating early detection in emergency or outpatient settings and aiding in the immediate initiation of treatment to reduce the risk of complications.

Diabetes Prevention:

Effective prevention and control strategies vary depending on the type of diabetes (Type I, Type II, and Gestational Diabetes).

1. Prevention Strategies Type I Diabetes

Genetic and Environmental Research: Type I diabetes cannot currently be prevented as it is an autoimmune condition with strong genetic and environmental components.

Immune Modulation: Immunotherapy or vaccines aimed at slowing or preventing autoimmune destruction of beta cells are under investigation.

Avoiding Environmental Triggers: Reducing exposure to certain viruses or environmental toxins might lower risk in predisposed individuals.

Control Strategies

  1. Insulin Therapy: Insulin therapy is a vital treatment option for people with both type I and type II diabetes. It helps regulate blood sugar levels by mimicking the action of insulin, a hormone naturally produced by the pancreas.
  2. Continuous Glucose Monitoring (CGM): CGM is a revolutionary technology that has significantly improved diabetes management. It provides real-time glucose readings, allowing individuals with diabetes to make informed decisions about their treatment and lifestyle. 
  3. Healthy Lifestyle: A healthy lifestyle is a cornerstone of diabetes management. By adopting healthy habits, individuals with diabetes can effectively control their blood sugar levels, reduce the risk of complications, and improve their overall quality of life. Balanced diet with consistent carbohydrate intake to match insulin dosing.
  4. Education and Support: Education and support are crucial components of diabetes management. They empower individuals with diabetes to make informed decisions, adopt healthy lifestyle changes, and effectively manage their condition.

2. Type II Diabetes

Prevention Strategies

Lifestyle Interventions:

Dietary Changes: Dietary changes are a crucial component of diabetes management. By making informed food choices and adopting healthy eating habits, individuals with diabetes can effectively control their blood sugar levels, reduce the risk of complications, and improve their overall health. Reduction in intake of processed foods, sugary drinks, and high-calorie diets and focus on high-fiber foods, whole grains, lean proteins, and healthy fats is best control strategy for diabetes control.

Physical Activity: Regular physical activity is a vital component of diabetes management. It helps improve insulin sensitivity, regulate blood sugar levels, and reduce the risk of diabetes-related complications.

Weight Management: Losing 5–7% of body weight can significantly reduce the risk of Type II in prediabetic individuals. Weight management is a key aspect of diabetes control, especially for individuals with type 2 diabetes. Excess weight can impair the body's ability to use insulin effectively, leading to higher blood sugar levels.

Screening and Early Intervention: Regular monitoring for individuals at high risk (e.g., family history, obesity, or history of gestational diabetes). Early detection and timely intervention are crucial for effective diabetes management. Regular screening can identify individuals at risk for developing type II diabetes or those who already have the condition without knowing it.

Medications: Medications play a crucial role in managing diabetes, especially for individuals who cannot control their blood sugar levels through lifestyle modifications alone. The type of medication prescribed depends on the specific type of diabetes and individual needs.


Sr.No

Category

Name of Drug

Brand

Mode of action

1

Insulin

Regular insulin

Humulin R

Humalog (lispro)

NovoLog (aspart)

Apidra (glulisine)

Fiasp (aspart)

Lyumjev (lispro)

Humulin N

Lantus (glargine)

Decrease glucose production and increase peripheral glucose uptake

2

Alpha glycoside inhibitor

Acarbose

Miglitor

Precose

Glyset

Decrease glucose absorption from intestine

3

Biguanides

Metformin phenformin

Glucophage DBI

Fortamet

Glumetza

Riomet

Decrease insulin resistance

4

Meglitinide

Repalinide Nateglinide

Prandin

starlix

Insulin secretagogues

5

Sulfonylurea

Tolbutamide

Orinase

Glimepiride

Glyburide

Glimiperide

Block the ATP sensitive potasium channels

6

Thiazolidinediones

Rosiglitazone

Pioglitazine

Avandia

Actos

Increase the insulin sensitivity


Public Health Initiatives: Public health initiatives play a vital role in preventing and managing diabetes. These initiatives aim to raise awareness, promote healthy lifestyles, and provide access to quality care. Community-based programs promoting healthy eating, active lifestyles, and awareness.

3. Gestational Diabetes (GDM)

Prevention Strategies

  1. Pre-pregnancy Planning: Pre-pregnancy planning involves a comprehensive strategy addressing lifestyle, medical management, and education to reduce the risk of gestational diabetes. Women at risk should engage with healthcare providers for personalized guidance, ensuring a healthy pregnancy and reducing complications for both mother and child.
  2. Healthy Pregnancy Practices: Maintaining a healthy pregnancy is essential for managing blood glucose levels and minimizing the risks associated with diabetes during pregnancy. Whether dealing with pre-existing diabetes (Type 1 or Type 2) or gestational diabetes mellitus (GDM), adopting healthy pregnancy practices can improve maternal and fetal outcomes. Healthy pregnancy practices for diabetes control focus on balanced nutrition, regular exercise, glucose monitoring, weight management, and adherence to medical advice. These strategies not only improve maternal and fetal health outcomes but also reduce the risk of long-term complications for both mother and child.
  3. Screening for GDM: Screening for gestational diabetes mellitus (GDM) is a vital control strategy that helps identify glucose intolerance during pregnancy, ensuring timely management to prevent complications for both mother and fetus. Early detection and intervention play a critical role in minimizing risks and improving outcomes. Universal screening between 24–28 weeks gestation using OGTT.

Control Strategies

  1. Dietary Management: Dietary management is a cornerstone of diabetes control, emphasizing balanced macronutrient intake to stabilize blood glucose. A low-glycemic index (GI) diet, rich in whole grains, legumes, vegetables, and lean proteins, mitigates postprandial glucose spikes. Adequate fiber enhances insulin sensitivity and delays carbohydrate absorption. Unsaturated fats from sources like nuts and olive oil reduce cardiovascular risks. Caloric intake is individualized based on energy needs to avoid weight gain or excessive loss. Regular meal timing minimizes glycemic variability, while reducing refined sugars prevents hyperglycemia. These scientifically driven dietary strategies promote sustained glycemic control, reducing complications and improving overall metabolic health.
  2. Physical Activity: Physical activity enhances insulin sensitivity and glucose uptake, making it a key strategy for diabetes management. Aerobic exercises, such as walking or cycling, improve cardiovascular health and facilitate glucose metabolism, while resistance training increases muscle mass, promoting better glucose utilization. Regular physical activity reduces fasting blood glucose, HbA1c levels, and insulin resistance. It aids in weight management, decreasing visceral fat linked to impaired glucose tolerance. These scientific approaches to physical activity improve glycemic control, reduce complications, and enhance overall metabolic health in diabetics.
  3. Glucose Monitoring: Glucose monitoring is a critical strategy in diabetes management, enabling real-time assessment of blood glucose levels to guide treatment. Self-monitoring of blood glucose identifies hyperglycemia and hypoglycemia, allowing timely interventions. Continuous glucose monitoring provides dynamic glucose trends, enhancing precision in insulin dosing and dietary adjustments. Frequent monitoring helps evaluate the effectiveness of interventions, promoting personalized care. Target ranges (e.g., fasting <95>

Postpartum Follow-Up: Postpartum follow-up is essential for managing diabetes, especially after gestational diabetes mellitus (GDM), to assess and mitigate long-term risks. Women with GDM require glucose tolerance testing 6–12 weeks postpartum to identify persistent hyperglycemia or prediabetes. Regular monitoring thereafter helps prevent progression to Type 2 diabetes. Lifestyle interventions, including a balanced diet and physical activity, are crucial for sustained glycemic control. Breastfeeding improves insulin sensitivity and lowers maternal blood glucose. Education on risk factors and preventive strategies ensures better adherence. Early postpartum follow-up provides a scientific framework to reduce future complications for both the mother and offspring.

REFERENCES

        1. Prof Paul Z Zimmet, Prof Dianna J Magliano, Prof William H Herman, Prof Jonathan E Shaw. Diabetes: a 21st century challenge. Volume 2, Issue 1p56-64January 2014. DOI: 10.1016/S2213-8587(13)70112-8.
        2. Anjali D Deshpande, Marcie Harris-Hayes, Mario Schootman, Epidemiology of Diabetes and Diabetes-Related Complications, Physical Therapy, Volume 88, Issue 11, 1 November 2008, Pages 1254–1264, DOI: https://doi.org/10.2522/ptj.20080020.
        3. Roglic, Gojka. WHO Global report on diabetes: A summary. International Journal of Noncommunicable Diseases 1(1):p 3-8, Apr–Jun 2016.  DOI: 10.4103/2468-8827.184853.
        4. Gale, E., Gillespie, K. Diabetes and gender. Diabetologia 44, 3–15 (2001). https://doi.org/10.1007/s001250051573.
        5. Amerigo Rossi, Mónica O Rossi, Camille Palarpalar, Lorenza Almonte, Alex Rothstein, Lillian B Niwagaba, Physical Activity Perceptions and Participation of People With Type II Diabetes Mellitus in the Dominican Republic, Cureus, 10.7759/cureus.62608, (2024).
        6. Rongping Chen, Jing Li, Danqi Chen, Weiheng Wen, Susu Zhang, Jitong Li, Yuting Ruan, Zhen Zhang, Jia Sun, Hong Chen, Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis, Diabetes, Metabolic Syndrome and Obesity, 10.2147/DMSO.S450994, Volume 17, (2471-2493), (2024).
        7. Pradeepa Sampath, Gurupriya Elangovan, Kaaveya Ravichandran, Vimal Shanmuganathan, Subbulakshmi Pasupathi, Tulika Chakrabarti, Prasun Chakrabarti, Martin Margala, Robust diabetic prediction using ensemble machine learning models with synthetic minority over-sampling technique, Scientific Reports, 10.1038/s41598-024-78519-8, 14, 1, (2024).
        8. Abhay Kumar Tripathi, Sumita Mishra, Shriram Kris Vasudevan, Real-Time Prediction of Diabetes Complications Using Regression-Based Machine Learning Models, Proceedings of the Fifth International Conference on Trends in Computational and Cognitive Engineering, 10.1007/978-981-97-1923-5_21, (271-285), (2024).
        9. Akhtar Ali, Farkhunda A Jaleel, Sadia A Waqar, Sehrish Ahmed, Noor Israr, Syed Wajid Shah, Comparison of Research Knowledge in Postgraduate Trainees of Clinical and Basic Health Sciences of a Tertiary Healthcare Setup: A Qualitative and Quantitative Assessment, Cureus, 10.7759/cureus.75251, (2024).
        10. https://diabetesatlas.org/regional-factsheets/
        11. https://www.who.int/news-room/fact-sheets/detail/diabetes
        12. Parameshappa B, Venkat RN, Shivaraj GT, Saikat S,Ashok RS, Shanta KumarSM. A  study on drug-drug interaction between anti-hypertensive drug and anti-diabetic drug.  Scholar research library, 2010; 1 (3):35-40.
        13. 2. Barar FSK.Essentials of pharmacotherapeutics, S Chand & company ltd.5th edition, 2009:347.
        14. Tripathi KD.Essentials of Medical Pharmacology, sixth edition,Jaypeebrother’s medical publishers(P) ltd. 2006: 267.
        15. Thomas P, Christian B. A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with Hypertension, the New England Journal of Medicine, 1989. 321(13):868-873.
        16. Desmond GH, ZhenPD, John LI, Propranolol prevents epinephrine from limiting insulin-stimulated muscle glucose uptake during contraction, J Appl Physiology,2002 93: 697-704.
        17. Christlieb AR, Warren JH, Krolewski AS, Hypertension: the major risk factor in juvenile onset insulin dependent diabetics, Diabetes Care, 1981; 30:90-96.
        18. Donovan M, Dalip R, Tara D, The effect of Captopril on blood glucose, plasma insulin and blood pressure via a nitric oxide independent mechanism in animal model, Diabetologia Croatica 2003: 125-131.
        19. Passa P, LeBlanc H, Marre M, Effect of enalpril in insulin dependent diabetic subjects  with mild to moderate uncomplicated hypertension, Diabetes Care, 1987;10:200-204.
        20. Kasiske BL, Kalil RSN, Ma JZ, Effect of antihypertensive therapy on the kidney in patient with diabetes: a meta-regression analysis, Ann Intern Med 1993; 118:129-138.
        21. Lipson LG,Special problems in treatment of hypertension in patient with diabetes mellitus, Arch Intern Med 1987; 144:1829-1831.
        22. Namdeo G. Shinde, Nagesh H. Aloorkar, Riyaz A. Osmani, Riyaz A. Osmani, Swati B. Udugade, Trushali A. Mandhare. Effect of Propranolol, Glipizide and its combination on Blood Glucose Level in Experimental Animal (MICE). International Journal of Innovative Research and Studies. Vol. 2 (9) p 252-257 (2013).

Reference

  1. Prof Paul Z Zimmet, Prof Dianna J Magliano, Prof William H Herman, Prof Jonathan E Shaw. Diabetes: a 21st century challenge. Volume 2, Issue 1p56-64January 2014. DOI: 10.1016/S2213-8587(13)70112-8.
  2. Anjali D Deshpande, Marcie Harris-Hayes, Mario Schootman, Epidemiology of Diabetes and Diabetes-Related Complications, Physical Therapy, Volume 88, Issue 11, 1 November 2008, Pages 1254–1264, DOI: https://doi.org/10.2522/ptj.20080020.
  3. Roglic, Gojka. WHO Global report on diabetes: A summary. International Journal of Noncommunicable Diseases 1(1):p 3-8, Apr–Jun 2016.  DOI: 10.4103/2468-8827.184853.
  4. Gale, E., Gillespie, K. Diabetes and gender. Diabetologia 44, 3–15 (2001). https://doi.org/10.1007/s001250051573.
  5. Amerigo Rossi, Mónica O Rossi, Camille Palarpalar, Lorenza Almonte, Alex Rothstein, Lillian B Niwagaba, Physical Activity Perceptions and Participation of People With Type II Diabetes Mellitus in the Dominican Republic, Cureus, 10.7759/cureus.62608, (2024).
  6. Rongping Chen, Jing Li, Danqi Chen, Weiheng Wen, Susu Zhang, Jitong Li, Yuting Ruan, Zhen Zhang, Jia Sun, Hong Chen, Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis, Diabetes, Metabolic Syndrome and Obesity, 10.2147/DMSO.S450994, Volume 17, (2471-2493), (2024).
  7. Pradeepa Sampath, Gurupriya Elangovan, Kaaveya Ravichandran, Vimal Shanmuganathan, Subbulakshmi Pasupathi, Tulika Chakrabarti, Prasun Chakrabarti, Martin Margala, Robust diabetic prediction using ensemble machine learning models with synthetic minority over-sampling technique, Scientific Reports, 10.1038/s41598-024-78519-8, 14, 1, (2024).
  8. Abhay Kumar Tripathi, Sumita Mishra, Shriram Kris Vasudevan, Real-Time Prediction of Diabetes Complications Using Regression-Based Machine Learning Models, Proceedings of the Fifth International Conference on Trends in Computational and Cognitive Engineering, 10.1007/978-981-97-1923-5_21, (271-285), (2024).
  9. Akhtar Ali, Farkhunda A Jaleel, Sadia A Waqar, Sehrish Ahmed, Noor Israr, Syed Wajid Shah, Comparison of Research Knowledge in Postgraduate Trainees of Clinical and Basic Health Sciences of a Tertiary Healthcare Setup: A Qualitative and Quantitative Assessment, Cureus, 10.7759/cureus.75251, (2024).
  10. https://diabetesatlas.org/regional-factsheets/
  11. https://www.who.int/news-room/fact-sheets/detail/diabetes
  12. Parameshappa B, Venkat RN, Shivaraj GT, Saikat S,Ashok RS, Shanta KumarSM. A  study on drug-drug interaction between anti-hypertensive drug and anti-diabetic drug.  Scholar research library, 2010; 1 (3):35-40.
  13. 2. Barar FSK.Essentials of pharmacotherapeutics, S Chand & company ltd.5th edition, 2009:347.
  14. Tripathi KD.Essentials of Medical Pharmacology, sixth edition,Jaypeebrother’s medical publishers(P) ltd. 2006: 267.
  15. Thomas P, Christian B. A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with Hypertension, the New England Journal of Medicine, 1989. 321(13):868-873.
  16. Desmond GH, ZhenPD, John LI, Propranolol prevents epinephrine from limiting insulin-stimulated muscle glucose uptake during contraction, J Appl Physiology,2002 93: 697-704.
  17. Christlieb AR, Warren JH, Krolewski AS, Hypertension: the major risk factor in juvenile onset insulin dependent diabetics, Diabetes Care, 1981; 30:90-96.
  18. Donovan M, Dalip R, Tara D, The effect of Captopril on blood glucose, plasma insulin and blood pressure via a nitric oxide independent mechanism in animal model, Diabetologia Croatica 2003: 125-131.
  19. Passa P, LeBlanc H, Marre M, Effect of enalpril in insulin dependent diabetic subjects  with mild to moderate uncomplicated hypertension, Diabetes Care, 1987;10:200-204.
  20. Kasiske BL, Kalil RSN, Ma JZ, Effect of antihypertensive therapy on the kidney in patient with diabetes: a meta-regression analysis, Ann Intern Med 1993; 118:129-138.
  21. Lipson LG,Special problems in treatment of hypertension in patient with diabetes mellitus, Arch Intern Med 1987; 144:1829-1831.
  22. Namdeo G. Shinde, Nagesh H. Aloorkar, Riyaz A. Osmani, Riyaz A. Osmani, Swati B. Udugade, Trushali A. Mandhare. Effect of Propranolol, Glipizide and its combination on Blood Glucose Level in Experimental Animal (MICE). International Journal of Innovative Research and Studies. Vol. 2 (9) p 252-257 (2013).

Photo
Akash Narbat
Corresponding author

Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad, Dr. Babasaheb Ambedkar Technological University, Lonere, Raigad MS India- 415509

Photo
Vaibhav Madane
Co-author

Mandesh Institute of Pharmaceutical Science and Research Center, Mhaswad, Dr. Babasaheb Ambedkar Technological University, Lonere, Raigad MS India- 415509

Photo
Namdeo Shinde
Co-author

Associate Professor, Shri Ganpati Institute of Pharmaceutical Sciences and Research, Tembhurni, Dr. Babasaheb Ambedkar Technological University, Lonere, Raigad MS India- 413211

Akash Narbat, Vaibhav Madane, Namdeo Shinde* Pathophysiology of Diabetes Mellitus with Disease Economics, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 2, 647-657. https://doi.org/10.5281/zenodo.14843855

More related articles
Formulation And Evaluation of Moisturising Cream C...
Mariyambi K. V., Aswathi V. V., Ismail M., Nafeesath K. P., Shaha...
The Intricate Landscape of Performance-Enhancing D...
Arnab Roy, K. Rajeswar Dutt, Mahesh Kumar Yadav, Asfaque Ali, Lax...
Therapeutic Drug Monitoring of Antimicrobials: A K...
Pratixa Patel, Dr. Arindam Paul, Dr. Hitesh Dalvadi, ...
An Overview of Ertugliflozin and Dapagliflozin in The Treatment of Diabetes Mell...
Mansi Shelke , Nikita Pabale , Vishweshwari Bhagat , Tanvi Kamble , Monali Khatake, ...
Comprehensive Phytochemical Profiling And Therapeutic Applications Of Plecosperm...
Dr. Mallappa Shalavadi, Devraj Chavan, Shivaraj Hiremath, Vinayaka Madivalar, Shubham Teli, ...
Estimation & Study of Eclipta prostrata for the treatment of Various Disease...
Dinesh Thore, Geeta Kaje, Rupali Jadhav, Pavanraj Lodwal, Nikhil Nikam, ...
Related Articles
Formulation And Evaluation of Wound Healing Cream Containing Tectona Grandis Ext...
Jyoti Prakash , Rajendra Kumar , Rukhmani Raman Sahu, Tilak Kumar Sinha, Mayank Borkar, Suchita Kuju...
Hepatoprotective Effect of Curcumin Microsponges against Paracetamol Induced Liv...
Gaurav Kasar, Pooja Rasal, Ritesh Khairnar, Revati Khairnar, Shubham Khaire, Yunus Ansari, Manoj Mah...
The Phytochemical And Pharmacological Review Article Of Fig Tree (Ficus Carica)...
Shaikh Mohammadsaad A., Patel Munavvar Y., Shaikh Umed K., Shaikh Rayyan J., Quazi Majaz , Aejaz Ahm...
Formulation and Evaluation of Kalanchoe Pinnata Syrup: A Pharmaceutical Dosage F...
Ravula Tulasi Naga Pavan Kumar, Boddani Sunil, Pattem Sirsha, Suma Sri Potti, Ayennedi Kusuma Lalith...
Formulation And Evaluation of Moisturising Cream Containing Coriander Leaves Ext...
Mariyambi K. V., Aswathi V. V., Ismail M., Nafeesath K. P., Shahala, Shamna K., ...
More related articles
Formulation And Evaluation of Moisturising Cream Containing Coriander Leaves Ext...
Mariyambi K. V., Aswathi V. V., Ismail M., Nafeesath K. P., Shahala, Shamna K., ...
The Intricate Landscape of Performance-Enhancing Drugs and Doping in Sports: Imp...
Arnab Roy, K. Rajeswar Dutt, Mahesh Kumar Yadav, Asfaque Ali, Laxman Kumar Mahto, Aman Sahu, Saurav ...
Therapeutic Drug Monitoring of Antimicrobials: A Key Component of Successful Pat...
Pratixa Patel, Dr. Arindam Paul, Dr. Hitesh Dalvadi, ...
Formulation And Evaluation of Moisturising Cream Containing Coriander Leaves Ext...
Mariyambi K. V., Aswathi V. V., Ismail M., Nafeesath K. P., Shahala, Shamna K., ...
The Intricate Landscape of Performance-Enhancing Drugs and Doping in Sports: Imp...
Arnab Roy, K. Rajeswar Dutt, Mahesh Kumar Yadav, Asfaque Ali, Laxman Kumar Mahto, Aman Sahu, Saurav ...
Therapeutic Drug Monitoring of Antimicrobials: A Key Component of Successful Pat...
Pratixa Patel, Dr. Arindam Paul, Dr. Hitesh Dalvadi, ...